TANG CAPITAL MANAGEMENT LLC Diversified Active

CIK: 0001232621 · Show all filings

Period: Q3 2016 (← Previous) (Next →)

Filing Date: Nov 15, 2016

Total Value ($000): $241,111 (90.9% shares, 9.1% debt)

Holdings (7)

HRTX HERON THERAPEUTICS INC 44.3%

Value ($000) $106,778 Shares 6,197,198 Est. Cost $13.95 Unrealized +33.0%

— LA JOLLA PHARMACEUTICAL CO 31.5%

Value ($000) $75,918 Shares 3,191,165 Est. Cost $15.19 Unrealized —

— IGNYTA INC 10.4%

Value ($000) $24,989 Shares 3,972,800 Est. Cost $5.43 Unrealized —

— OPKO HEALTH INC 9.1%

Value ($000) $22,031 Shares 14,000,000 Est. Cost $1.47 Unrealized —

BMRN BIOMARIN PHARMACEUTICAL INC 3.5%

Value ($000) $8,347 Shares 90,215 Est. Cost $62.32 Unrealized +51.1%

— CYCLACEL PHARMACEUTICALS INC 0.9%

Value ($000) $2,159 Shares 359,900 Est. Cost $6.00 Unrealized —

— ATYR PHARMA INC 0.4%

Value ($000) $889 Shares 279,425 Est. Cost $3.57 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
HRTX	HERON THERAPEUTICS INC	6,197,198	$106,778	44.3%	$13.95	+33.0%	COM	427746102
—	LA JOLLA PHARMACEUTICAL CO	3,191,165	$75,918	31.5%	$15.19	—	COM	503459604
—	IGNYTA INC	3,972,800	$24,989	10.4%	$5.43	—	COM	451731103
—	OPKO HEALTH INC	14,000,000	$22,031	9.1%	$1.47	—	DEBT 3.0% 2/1/33	68375NAB9
BMRN	BIOMARIN PHARMACEUTICAL INC	90,215	$8,347	3.5%	$62.32	+51.1%	COM	09061G101
—	CYCLACEL PHARMACEUTICALS INC	359,900	$2,159	0.9%	$6.00	—	COM	23254L405
—	ATYR PHARMA INC	279,425	$889	0.4%	$3.57	—	COM	002120103